DOTA-Octreotide TFA

Description: DOTA-Octreotide TFA consists of the chelating agent DOTA and Octreotide. It is utilized in cancer research through its ability to bind with radioactive elements and is also employed in the synthesis and study of radiolabeled conjugate drugs (RDC). Smiles: C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)N[C@H](CO)[C@@H](C)O)O.C(=O)(C(F)(F)F)O